Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.871 |
High Similarity |
NPD422 |
Phase 1 |
0.8626 |
High Similarity |
NPD5124 |
Phase 1 |
0.8626 |
High Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.8258 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.8162 |
Intermediate Similarity |
NPD3748 |
Approved |
0.812 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.812 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8067 |
Intermediate Similarity |
NPD9697 |
Approved |
0.8058 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8049 |
Intermediate Similarity |
NPD5535 |
Approved |
0.8042 |
Intermediate Similarity |
NPD920 |
Approved |
0.8031 |
Intermediate Similarity |
NPD5691 |
Approved |
0.8 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7971 |
Intermediate Similarity |
NPD2796 |
Approved |
0.797 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7929 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7887 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7879 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7879 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7872 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7846 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7812 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7787 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7721 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7718 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7708 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7704 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7703 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7676 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7643 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7634 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7609 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7609 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7606 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7594 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7576 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7566 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7534 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7518 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7517 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD919 |
Approved |
0.75 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7483 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7465 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7465 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7464 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7424 |
Intermediate Similarity |
NPD17 |
Approved |
0.7422 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7397 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7397 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7394 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7394 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7388 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7379 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7357 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7347 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7328 |
Intermediate Similarity |
NPD7644 |
Approved |
0.732 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7319 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7305 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7302 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7299 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7299 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7293 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7292 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7292 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7292 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7292 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7259 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7255 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD1607 |
Approved |
0.725 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7248 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7241 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7234 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7234 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7218 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7214 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7209 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7208 |
Intermediate Similarity |
NPD4288 |
Approved |
0.72 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7185 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7181 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7181 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7181 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7176 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7172 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7172 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7163 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7154 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7133 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7132 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7132 |
Intermediate Similarity |
NPD1137 |
Approved |
0.7132 |
Intermediate Similarity |
NPD1139 |
Approved |
0.7122 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7122 |
Intermediate Similarity |
NPD2237 |
Approved |
0.7115 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7115 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7111 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7103 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7103 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7103 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7103 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7097 |
Intermediate Similarity |
NPD846 |
Approved |
0.7097 |
Intermediate Similarity |
NPD940 |
Approved |
0.7097 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7083 |
Intermediate Similarity |
NPD2200 |
Suspended |
0.7083 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.708 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.708 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.708 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7077 |
Intermediate Similarity |
NPD1138 |
Approved |
0.7073 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7071 |
Intermediate Similarity |
NPD2614 |
Approved |
0.7068 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7067 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7063 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7059 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7055 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.705 |
Intermediate Similarity |
NPD2798 |
Approved |
0.705 |
Intermediate Similarity |
NPD3690 |
Phase 2 |
0.705 |
Intermediate Similarity |
NPD3691 |
Phase 2 |
0.7045 |
Intermediate Similarity |
NPD6387 |
Discontinued |
0.7045 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7037 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7029 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7027 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7021 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7015 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD3226 |
Approved |
0.6993 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6986 |
Remote Similarity |
NPD2438 |
Suspended |
0.6981 |
Remote Similarity |
NPD1247 |
Approved |
0.6981 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6977 |
Remote Similarity |
NPD5451 |
Approved |
0.6972 |
Remote Similarity |
NPD411 |
Approved |
0.6972 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD1934 |
Approved |
0.6963 |
Remote Similarity |
NPD1651 |
Approved |
0.6959 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD4359 |
Approved |
0.6957 |
Remote Similarity |
NPD5327 |
Phase 3 |
0.6954 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6953 |
Remote Similarity |
NPD290 |
Approved |
0.6944 |
Remote Similarity |
NPD447 |
Suspended |
0.6943 |
Remote Similarity |
NPD3882 |
Suspended |
0.6939 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6937 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6934 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD6652 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6917 |
Remote Similarity |
NPD2557 |
Approved |
0.6914 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6913
|
Remote Similarity |
NPD3892 |
Phase 2 |